
Aug 20, 2025, 22:08
Devon J Shedlock Named Vice President and Head of Oncology Cell Therapy Technology at Genentech
Devon J Shedlock, Vice President and Head of Oncology Cell Therapy Technology at Genentech, shared a post on LinkedIn:
“I’m happy to share that I’m starting a new position as Vice President, Head of Oncology Cell Therapy Technology at Genentech!”
More posts featuring Genentech on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 20, 2025, 21:51
Aug 20, 2025, 21:35
Aug 20, 2025, 18:26